{"id":"https://openalex.org/W1964538442","doi":"https://doi.org/10.1097/00004850-200015030-00006","title":"Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms","display_name":"Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms","alternate_titles":[],"publication_year":2000,"publication_date":"2000-05-01","ids":{"openalex":"https://openalex.org/W1964538442","doi":"https://doi.org/10.1097/00004850-200015030-00006","mag":"1964538442","pmid":"https://pubmed.ncbi.nlm.nih.gov/10870875"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-200015030-00006","doi":"https://doi.org/10.1097/00004850-200015030-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200015030-00006","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964538442"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061817231","display_name":"Michael Poyurovsky","orcid":"https://orcid.org/0000-0003-3525-5743","observed_orcids":["https://orcid.org/0000-0003-3525-5743"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210152234","display_name":"Tirat Carmel Mental Health Center","ror":"https://ror.org/04jjkfw48","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210152234"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Poyurovsky","raw_affiliation_strings":["Research Unit, Tirat Carmel Mental Health Center, Faculty of Medicine, Technion, Israel Institute of Technology, Haifa","Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel, Faculty of Medicine, Technion, Israel Institute of Technology, Haifa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Unit, Tirat Carmel Mental Health Center, Faculty of Medicine, Technion, Israel Institute of Technology, Haifa","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210152234"]},{"raw_affiliation_string":"Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel, Faculty of Medicine, Technion, Israel Institute of Technology, Haifa","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210152234"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074192515","display_name":"Pnina Dorfman-Etrog","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Dorfman-Etrog","raw_affiliation_strings":["Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048746026","display_name":"Haggai Hermesh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Haggai Hermesh","raw_affiliation_strings":["Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052298362","display_name":"Hanan Munitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Munitz","raw_affiliation_strings":["Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109214489","display_name":"Gary D. Tollefson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. D. Tollefson","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063898483","display_name":"Abraham Weizman","orcid":"https://orcid.org/0000-0002-9765-8938","observed_orcids":["https://orcid.org/0000-0002-9765-8938"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I4210143993","display_name":"Geha Mental Health Center","ror":"https://ror.org/03tp0ty93","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210143993","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"A. Weizman","raw_affiliation_strings":["Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and","to A. Weizman, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva 49100, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Felsenstein Medical Research Center and Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel and","institution_ids":["https://openalex.org/I16391192"]},{"raw_affiliation_string":"to A. Weizman, Geha Psychiatric Hospital, Beilinson Campus, Petah Tiqva 49100, Israel","institution_ids":["https://openalex.org/I4210143993"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5063898483"],"corresponding_institution_ids":["https://openalex.org/I16391192","https://openalex.org/I4210143993"],"apc_list":null,"apc_paid":null,"fwci":2.3111,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.87225308,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"15","issue":"3","first_page":"169","last_page":"173"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8970000147819519},{"id":"https://openalex.org/keywords/obsessive-compulsive-symptoms","display_name":"obsessive-compulsive symptoms","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9800000190734863},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":0.8130000233650208},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.984000027179718},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.5609999895095825},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.4429999887943268},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.9267253875732422},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.7206037044525146},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.7147862911224365},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.6656553149223328},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.5767412185668945},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5743476748466492},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5358043909072876},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4522739350795746},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3680014908313751},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3361944258213043},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.32058611512184143},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.10173436999320984},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-200015030-00006","doi":"https://doi.org/10.1097/00004850-200015030-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200015030-00006","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:10870875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10870875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W26647938","https://openalex.org/W1963782308","https://openalex.org/W2381738678","https://openalex.org/W1995629821","https://openalex.org/W3206643666","https://openalex.org/W4387574032","https://openalex.org/W62794487","https://openalex.org/W2092227038","https://openalex.org/W2025295645","https://openalex.org/W1986864326"],"abstract_inverted_index":{"Some":[0],"studies":[1],"suggest":[2,171],"that":[3,54,172],"obsessive-compulsive":[4,47,60,74,117,183],"symptoms":[5,61,75,118],"may":[6,34,174],"be":[7,16,35,175],"common":[8],"(7.8-46%)":[9],"in":[10,62,84,113,179],"schizophrenic":[11,63,71,115,180],"patients":[12,72,108,181],"and":[13,89,116,128,153,155,162],"seem":[14],"to":[15,19,95,102],"poorly":[17],"responsive":[18],"drug":[20],"therapy.":[21],"Conventional":[22],"neuroleptics":[23,83],"are":[24],"of":[25,98,138,140,145],"limited":[26],"value,":[27],"but":[28],"adjunctive":[29],"anti-obsessive":[30,87],"agents":[31,88],"(clomipramine,":[32],"fluvoxamine)":[33],"an":[36],"option.":[37],"Although":[38],"novel":[39],"atypical":[40],"antipsychotics":[41],"(clozapine,":[42],"risperidone)":[43],"reportedly":[44],"aggravate":[45],"the":[46,122,129,142,146,156],"symptoms,":[48],"a":[49,110,176],"recent":[50],"trial":[51],"has":[52],"shown":[53],"olanzapine":[55,103,173],"did":[56],"not":[57],"induce":[58],"new-onset":[59],"patients.":[64],"We":[65],"report":[66],"our":[67],"experience":[68],"with":[69,73,80,86,182],"three":[70,147],"who":[76],"were":[77,100],"unsuccessfully":[78],"treated":[79],"various":[81],"conventional":[82],"combination":[85],"subsequently":[90],"showed":[91],"resistance":[92],"or":[93],"intolerance":[94],"clozapine.":[96],"All":[97,107],"them":[99],"switched":[101],"(10-20":[104],"mg/":[105],"day).":[106],"demonstrated":[109],"significant":[111],"improvement":[112],"both":[114],"as":[119],"measured":[120],"by":[121,150,159],"Brief":[123],"Psychiatric":[124],"Rating":[125],"Scale":[126,133],"(BPRS)":[127],"Yale-Brown":[130],"Obsessive":[131],"Compulsive":[132],"(Y-BOCS).":[134],"Within":[135],"5-8":[136],"weeks":[137],"initiation":[139],"olanzapine,":[141],"BPRS":[143],"scores":[144,158],"patient":[148],"decreased":[149],"53%,":[151],"51%":[152],"48%,":[154],"Y-BOCS":[157],"68%,":[160],"73%":[161],"85%.":[163],"Olanzapine":[164],"was":[165],"well":[166],"tolerated.":[167],"These":[168],"preliminary":[169],"results":[170],"therapeutic":[177],"option":[178],"symptoms.":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964538442","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
